Marc Tessier-Lavigne
Canadian neuroscientist (born 1959)
Marc Trevor Tessier-Lavigne (born December 18, 1959) is a Canadian-American neuroscientist who is the co-founder, CEO, and chair of the AI biotechnology firm Xaira Therapeutics. He is also a biology professor at Stanford University, where he served as its 11th president from 2016 until his resignation in 2023.2
From Wikipedia’s article on Marc Tessier-Lavigne (this version), CC BY-SA 4.0.
Born Dec 18, 1959.1
About
Tessier-Lavigne was formerly executive vice president for research and the chief scientific officer at Genentech. In 2011, he joined the boards of directors of Agios Pharmaceuticals, Regeneron Pharmaceuticals, and Pfizer. In 2014, he joined the board of Juno Therapeutics, and in 2015 he co-founded Denali Therapeutics and joined its board. Tessier-Lavigne was the 10th president of Rockefeller University in New York City from 2011 to 2016, and a professor at the University of California, San Francisco.
In 2022, the Stanford board of trustees opened an investigation into alleged research misconduct by Tessier-Lavigne. The board's investigation found that four papers co-authored by Tessier-Lavigne contained "apparent manipulation of research data", though the report cleared Tessier-Lavigne himself of intentional misconduct. Upon the report's release, Tessier-Lavigne announced his resignation as president of Stanford, effective August 31, 2023.
From Wikipedia’s article on Marc Tessier-Lavigne, shared under CC BY-SA 4.0.2
Companies
- Stanford UniversityPresident 2016 to now3
- Stanford UniversityChair Sep 1, 2016 to Mar 31, 20233
Links
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataMarc Tessier-Lavigne on Wikidata
- 2WikipediaMarc Tessier-Lavigne on Wikipedia
- 3WikidataStanford University, President